102 related articles for article (PubMed ID: 38798568)
1. Auranofin and reactive oxygen species inhibit protein synthesis and regulate the level of the PLK1 protein in Ewing sarcoma cells.
Haight JA; Koppenhafer SL; Geary EL; Gordon DJ
bioRxiv; 2024 May; ():. PubMed ID: 38798568
[TBL] [Abstract][Full Text] [Related]
2. The translational repressor 4E-BP1 regulates RRM2 levels and functions as a tumor suppressor in Ewing sarcoma tumors.
Goss KL; Koppenhafer SL; Waters T; Terry WW; Wen KK; Wu M; Ostergaard J; Gordon PM; Gordon DJ
Oncogene; 2021 Jan; 40(3):564-577. PubMed ID: 33191406
[TBL] [Abstract][Full Text] [Related]
3. mTORC1/2 and Protein Translation Regulate Levels of CHK1 and the Sensitivity to CHK1 Inhibitors in Ewing Sarcoma Cells.
Koppenhafer SL; Goss KL; Terry WW; Gordon DJ
Mol Cancer Ther; 2018 Dec; 17(12):2676-2688. PubMed ID: 30282812
[TBL] [Abstract][Full Text] [Related]
4. Activator Protein-1 (AP-1) Signaling Inhibits the Growth of Ewing Sarcoma Cells in Response to DNA Replication Stress.
Croushore EE; Koppenhafer SL; Goss KL; Geary EL; Gordon DJ
Cancer Res Commun; 2023 Aug; 3(8):1580-1593. PubMed ID: 37599787
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the ATR-CHK1 Pathway in Ewing Sarcoma Cells Causes DNA Damage and Apoptosis via the CDK2-Mediated Degradation of RRM2.
Koppenhafer SL; Goss KL; Terry WW; Gordon DJ
Mol Cancer Res; 2020 Jan; 18(1):91-104. PubMed ID: 31649026
[TBL] [Abstract][Full Text] [Related]
6. Eltrombopag inhibits the proliferation of Ewing sarcoma cells via iron chelation and impaired DNA replication.
Waters T; Goss KL; Koppenhafer SL; Terry WW; Gordon DJ
BMC Cancer; 2020 Nov; 20(1):1171. PubMed ID: 33256675
[TBL] [Abstract][Full Text] [Related]
7. In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma.
Pessetto ZY; Chen B; Alturkmani H; Hyter S; Flynn CA; Baltezor M; Ma Y; Rosenthal HG; Neville KA; Weir SJ; Butte AJ; Godwin AK
Oncotarget; 2017 Jan; 8(3):4079-4095. PubMed ID: 27863422
[TBL] [Abstract][Full Text] [Related]
8. RNA helicase DDX3: a novel therapeutic target in Ewing sarcoma.
Wilky BA; Kim C; McCarty G; Montgomery EA; Kammers K; DeVine LR; Cole RN; Raman V; Loeb DM
Oncogene; 2016 May; 35(20):2574-83. PubMed ID: 26364611
[TBL] [Abstract][Full Text] [Related]
9. Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma.
Goss KL; Gordon DJ
Oncotarget; 2016 Sep; 7(39):63003-63019. PubMed ID: 27557498
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine.
Goss KL; Koppenhafer SL; Harmoney KM; Terry WW; Gordon DJ
Oncotarget; 2017 Oct; 8(50):87016-87032. PubMed ID: 29152060
[TBL] [Abstract][Full Text] [Related]
11. Targeting Glutathione S-transferase M4 in Ewing sarcoma.
Zhuo R; Kosak KM; Sankar S; Wiles ET; Sun Y; Zhang J; Ayello J; Prestwich GD; Shami PJ; Cairo MS; Lessnick SL; Luo W
Front Pediatr; 2014; 2():83. PubMed ID: 25147782
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of action of auranofin analogs in
Maydaniuk DT; Martens B; Iqbal S; Hogan AM; Lorente Cobo N; Motnenko A; Truong D; Liyanage SH; Yan M; Prehna G; Cardona ST
Microbiol Spectr; 2024 Feb; 12(2):e0320123. PubMed ID: 38206016
[TBL] [Abstract][Full Text] [Related]
13. Synergistic lethality between auranofin-induced oxidative DNA damage and ATR inhibition in cancer cells.
Zhang S; Zhao Y; Wang X; Qi C; Tian J; Zou Z
Life Sci; 2023 Nov; 332():122131. PubMed ID: 37778414
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of DNA binding 2 (ID2) regulates the expression of developmental genes and tumorigenesis in ewing sarcoma.
Koppenhafer SL; Goss KL; Voigt E; Croushore E; Terry WW; Ostergaard J; Gordon PM; Gordon DJ
Oncogene; 2022 May; 41(20):2873-2884. PubMed ID: 35422476
[TBL] [Abstract][Full Text] [Related]
15. Methionine restriction exposes a targetable redox vulnerability of triple-negative breast cancer cells by inducing thioredoxin reductase.
Malin D; Lee Y; Chepikova O; Strekalova E; Carlson A; Cryns VL
Breast Cancer Res Treat; 2021 Dec; 190(3):373-387. PubMed ID: 34553295
[TBL] [Abstract][Full Text] [Related]
16. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
[TBL] [Abstract][Full Text] [Related]
17. EWS-FLI1-regulated Serine Synthesis and Exogenous Serine are Necessary for Ewing Sarcoma Cellular Proliferation and Tumor Growth.
Issaq SH; Mendoza A; Kidner R; Rosales TI; Duveau DY; Heske CM; Rohde JM; Boxer MB; Thomas CJ; DeBerardinis RJ; Helman LJ
Mol Cancer Ther; 2020 Jul; 19(7):1520-1529. PubMed ID: 32371575
[TBL] [Abstract][Full Text] [Related]
18. eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer.
Müller D; Shin S; Goullet de Rugy T; Samain R; Baer R; Strehaiano M; Masvidal-Sanz L; Guillermet-Guibert J; Jean C; Tsukumo Y; Sonenberg N; Marion F; Guilbaud N; Hoffmann JS; Larsson O; Bousquet C; Pyronnet S; Martineau Y
JCI Insight; 2019 Nov; 4(21):. PubMed ID: 31672935
[TBL] [Abstract][Full Text] [Related]
19. Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma
Huang R; Huang D; Wang S; Xian S; Liu Y; Jin M; Zhang X; Chen S; Yue X; Zhang W; Lu J; Liu H; Huang Z; Zhang H; Yin H
Front Genet; 2022; 13():952162. PubMed ID: 36092920
[No Abstract] [Full Text] [Related]
20. Icariside II, a natural mTOR inhibitor, disrupts aberrant energy homeostasis via suppressing mTORC1-4E-BP1 axis in sarcoma cells.
Zhang C; Yang L; Geng YD; An FL; Xia YZ; Guo C; Luo JG; Zhang LY; Guo QL; Kong LY
Oncotarget; 2016 May; 7(19):27819-37. PubMed ID: 27056897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
